TP53 and breast cancer: To test the hypothesis that CSF1/CSF1R signaling through p53 may underlie the increased radio-resistance associated with this pathway in breast cancer cells, we next assessed the radiation sensitivity of our Vector-infected and CSF1R-infected cells, in the presence and absence of doxycycline to induce p53.